Avidity Partners Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Avidity Partners Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,869,200	Closed	-$45.5M	–	112
2023 Q1	$45.5M	Buy	1,869,200 +1,030,793	+123%	+$22.6M	1.51%	25
2022 Q4	$18M	Buy	+838,407	New	+$17.9M	0.39%	55
2022 Q3	–	Sell	-430,117	Closed	-$4.14M	–	110
2022 Q2	$4.14M	Sell	430,117 -6,045,283	-93%	-$75.9M	0.1%	64
2022 Q1	$109M	Sell	6,475,400 -479,600	-7%	-$7.09M	2.27%	16
2021 Q4	$116M	Buy	6,955,000 +2,855,000	+70%	+$46.8M	2.47%	11
2021 Q3	$66.6M	Buy	4,100,000 +2,699,990	+193%	+$29.4M	1.48%	24
2021 Q2	$8.83M	Buy	+1,400,010	New	+$9.03M	0.24%	73

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Avidity Partners Management's ISEE Position: Q2 2023 in Review

Avidity Partners Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 1,869,200 shares — an estimated $45.5M sold.

Avidity Partners Management first reported a position in ISEE in Q2 2021 and held it in 7 quarters. The position peaked at $116M in Q4 2021. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

Avidity Partners Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Avidity Partners Management sold 1,869,200 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $45.5M.
Avidity Partners Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2021 and held it in 7 quarters.
Avidity Partners Management's IVERIC bio, Inc. Common Stock position peaked at $116M in Q4 2021.
256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Avidity Partners Management's 13F filing for Q2 2023, filed 14 Aug 2023.